A randomized, observer-blind, controlled trial of the traditional Chinese medicine Yi-Gan San for improvement of behavioral and psychological symptoms and activities of daily living in dementia patients.

A randomized, observer-blind, controlled trial of the traditional Chinese medicine Yi-Gan San for improvement of behavioral and psychological symptoms and activities of daily living in dementia patients.

Item

http://www.wikidata.org/entity/Q34554967

Q34554967

about

The use of herbal medicine in Alzheimer's disease-a systematic review Behavioral Abnormality Induced by Enhanced Hypothalamo-Pituitary-Adrenocortical Axis Activity under Dietary Zinc Deficiency and Its Usefulness as a Model Yokukan-san: a review of the evidence for use of this Kampo herbal formula in dementia and psychiatric conditions Hypnotics and the Occurrence of Bone Fractures in Hospitalized Dementia Patients: A Matched Case-Control Study Using a National Inpatient Database Daily administration of yokukansan and keishito prevents social isolation-induced behavioral abnormalities and down-regulation of phosphorylation of neuroplasticity-related signaling molecules in mice Yi-gan san restores behavioral alterations and a decrease of brain glutathione level in a mouse model of schizophrenia Traditional chinese medicine for chronic fatigue syndrome.Yokukansan and its ingredients as possible treatment options for schizophrenia.Yokukansan (TJ-54) for treatment of pervasive developmental disorder not otherwise specified and Asperger's disorder: a 12-week prospective, open-label study.Yokukansan promotes hippocampal neurogenesis associated with the suppression of activated microglia in Gunn rat.Drug discovery from Chinese medicine against neurodegeneration in Alzheimer's and vascular dementia Traditional Japanese Kampo Medicine: Clinical Research between Modernity and Traditional Medicine-The State of Research and Methodological Suggestions for the Future An antioxidant phytotherapy to rescue neuronal oxidative stress.Specific binding and characteristics of 18β-glycyrrhetinic acid in rat brain.Inhibitory activities of selected Kampo formulations on human aldose reductase Ameliorating effect of Yokukansan on the development of atopic dermatitis-like lesions and scratching behavior in socially isolated NC/Nga mice.Yokukansan, a kampo medicine, protects PC12 cells from glutamate-induced death by augmenting gene expression of cystine/glutamate antiporter system Xc-.Efficacy and safety of yokukansan in treatment-resistant schizophrenia: a randomized, multicenter, double-blind, placebo-controlled trial.Antiallodynic effect of herbal medicine yokukansan on peripheral neuropathy in rats with chronic constriction injury.Effect of toki-shakuyaku-san on regional cerebral blood flow in patients with mild cognitive impairment and Alzheimer's disease.New possibility of traditional Chinese and Japanese medicine as treatment for behavioral and psychiatric symptoms in dementia Traditional Chinese medicine: a promising candidate for the treatment of Alzheimer's disease Yokukansan improves behavioral and psychological symptoms of dementia by suppressing dopaminergic function.A valid approach in refractory glossodynia: a single-institution 5-year experience treating with Japanese traditional herbal (kampo) medicine Efficacy of Japanese traditional (Kampo) medicine for treating chemotherapy-induced peripheral neuropathy: A retrospective case series study.Compound danshen tablet ameliorated aβ25-35-induced spatial memory impairment in mice via rescuing imbalance between cytokines and neurotrophins.Treatment of posttraumatic stress disorder using the traditional Japanese herbal medicine saikokeishikankyoto: a randomized, observer-blinded, controlled trial in survivors of the great East Japan earthquake and tsunami Serotonin Receptor Binding Characteristics of Geissoschizine Methyl Ether, an Indole Alkaloid in Uncaria Hook.Multiple Psychopharmacological Effects of the Traditional Japanese Kampo Medicine Yokukansan, and the Brain Regions it Affects.Herbal therapy: a new pathway for the treatment of Alzheimer's disease Yokukansan and Yokukansankachimpihange Ameliorate Aggressive Behaviors in Rats with Cholinergic Degeneration in the Nucleus Basalis of Meynert.Antistress effects of Kampo medicine "Yokukansan" via regulation of orexin secretion.Potential usefulness of the kampo medicine yokukansan, containing uncaria hook, for paediatric emotional and behavioural disorders: a case series Liquorice-induced hypokalaemia in patients treated with Yokukansan preparations: identification of the risk factors in a retrospective cohort study.Cellular Pharmacological Effects of the Traditional Japanese Kampo Medicine Yokukansan on Brain Cells.Influences of yokukansankachimpihange on aggressive behavior of zinc-deficient mice and actions of the ingredients on excessive neural exocytosis in the hippocampus of zinc-deficient rats.Energetics of Excitatory and Inhibitory Neurotransmission in Aluminum Chloride Model of Alzheimer's Disease: Reversal of Behavioral and Metabolic Deficits by Rasa Sindoor.Using Complementary and Alternative Medicine to Treat Pain and Agitation in Dementia: A Review of Randomized Controlled Trials from Long-Term Care with Potential Use in Critical Care.The Kampo medicine Yokukansan (YKS) enhances nerve growth factor (NGF)-induced neurite outgrowth in PC12 cells.Isorhynchophylline alleviates learning and memory impairments induced by aluminum chloride in mice.

P2860

Q24673334-719775A3-3A45-41E8-83B3-D8FD4BEE1355 Q26738739-FF719296-2D63-4063-8A4C-A7C61AAA8DD0 Q27022174-600F0312-37A8-4C14-971A-7BC5508FE945 Q28548098-F221211D-862A-4DD1-99AB-592BC2AF12BD Q30359204-6F14892F-ED60-4827-B568-CA81D2DB6EC4 Q30452926-CC739021-7D80-4987-9421-DB3D170A4458 Q30483511-A312D523-1AC9-44BB-9DBE-DB405A3C450D Q34140742-94079E58-0CE0-48F5-98D8-F864C66FE267 Q34495483-15243929-3891-4C68-9E74-278B52D20B21 Q34524383-68C3A5CB-8E76-4788-AF25-A872D5F998E0 Q34989295-229F499F-5355-4E32-8B46-59AF9DDA9DF3 Q35043493-88BAC616-702B-4351-9BC7-C192EF9CCADB Q35116479-BE9FE6D0-6C4A-4695-96DB-3E943CF99A3F Q35154276-4A39829A-3322-49BE-BE72-4ACC98A97D15 Q35397913-189D74A7-7A9A-4AEE-9153-B4AD480CE51C Q35402761-5522910D-AB42-4D03-A138-65874A09D9C6 Q35536534-5FF8F792-4DEC-40B9-87BB-E843694B1606 Q35543762-AB10A0DC-35DC-4F8D-B412-EFE48E02A81B Q35796363-309A159D-9BAD-476B-87BD-E5F438FBD8C1 Q35796586-0D106F44-1891-4646-B063-EA3095ACED98 Q36307873-180C33B2-79A6-433B-8DAA-A061B02F4E2C Q36689057-2121770A-9B01-4AAD-BFDD-E4E44E9FD1B6 Q36710267-5C165B74-29B8-4F39-B27B-150D61E50EDC Q37275236-05649066-6AF7-4200-B468-A4249BFB4E49 Q37345334-BB4A82F2-3817-4C31-9761-96DA6D9EA850 Q37502879-DFD50D3C-F16F-4247-95AF-B67117965F2B Q37695924-41AD55E8-E032-4235-810F-7E10CD6330AF Q38891602-FE51EB6E-6527-4CAD-B077-D8F932058F00 Q39220519-0B0D528C-6811-4E31-B2A8-1F3983F080A3 Q39818663-002AF75E-2638-4FC7-9620-E628B627C4F8 Q41790670-462E80FD-7337-42D1-AB00-4976E5F8D0F6 Q42112352-E3A51EA4-5D58-41B3-B18B-A8645CC314C2 Q42167149-85D5D0F4-C975-4CBE-9374-3BB8E9E516E7 Q42267822-8DB93382-472D-4D89-BE36-F6D833970A43 Q42363344-4551E104-9D87-4039-A839-97D256264B44 Q42367703-88795372-AF08-44CB-A0E7-18CA5C1927EB Q47167624-7699457B-A2DB-40C4-B1F6-2256D6BB45E2 Q50138350-60C6EF64-8C31-42BD-96A9-42AEA4FC58E6 Q53053726-55504856-1386-4BC7-9ED0-5C2F8B271E41 Q55446416-DBD06E6C-92EE-499E-9F13-99E218D4D173

P2860

A randomized, observer-blind, controlled trial of the traditional Chinese medicine Yi-Gan San for improvement of behavioral and psychological symptoms and activities of daily living in dementia patients.

Item

http://www.wikidata.org/entity/Q34554967

description

2005 nî lūn-bûn

@nan

2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu